Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England

被引：63

作者：

Grint, Daniel J. ^{[1
]}

Wing, Kevin ^{[1
]}

Houlihan, Catherine ^{[2
]}

Gibbs, Hamish P. ^{[1
]}

Evans, Stephen J. W. ^{[1
]}

Williamson, Elizabeth ^{[1
]}

McDonald, Helen, I ^{[1
]}

Bhaskaran, Krishnan ^{[1
]}

Evans, David ^{[3
]}

Walker, Alex J. ^{[3
]}

Hickman, George ^{[3
]}

Nightingale, Emily ^{[4
]}

Schultze, Anna ^{[1
]}

Rentsch, Christopher T. ^{[1
]}

Bates, Chris ^{[5
]}

Cockburn, Jonathan ^{[5
]}

Curtis, Helen J. ^{[3
]}

Morton, Caroline E. ^{[3
]}

Bacon, Sebastian ^{[3
]}

Davy, Simon ^{[3
]}

Wong, Angel Y. S. ^{[1
]}

Mehrkar, Amir ^{[3
]}

Tomlinson, Laurie ^{[1
]}

Douglas, Ian J. ^{[1
]}

Mathur, Rohini ^{[1
]}

MacKenna, Brian ^{[3
]}

Ingelsby, Peter ^{[3
]}

Croker, Richard ^{[3
]}

Parry, John ^{[5
]}

Hester, Frank ^{[5
]}

Harper, Sam ^{[5
]}

DeVito, Nicholas J. ^{[3
]}

Hulme, Will ^{[3
]}

Tazare, John ^{[1
]}

Smeeth, Liam ^{[1
]}

Goldacre, Ben ^{[3
]}

Eggo, Rosalind M. ^{[1
]}

机构：

[1] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England

[2] UCL, Div Infect & Immun, London, England

[3] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, DataLab, Oxford, England

[4] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England

[5] TPP, Leeds, W Yorkshire, England

来源：

CLINICAL INFECTIOUS DISEASES | 2022年 / 75卷 / 01期

基金：

英国科研创新办公室; 英国医学研究理事会;

关键词：

SARS-CoV-2; alpha; case fatality; hospital admission;

D O I：

10.1093/cid/ciab754

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) alpha variant (B.1.1.7) is associated with higher transmissibility than wild-type virus, becoming the dominant variant in England by January 2021. We aimed to describe the severity of the alpha variant in terms of the pathway of disease from testing positive to hospital admission and death. Methods With the approval of NHS England, we linked individual-level data from primary care with SARS-CoV-2 community testing, hospital admission, and Office for National Statistics all-cause death data. We used testing data with S-gene target failure as a proxy for distinguishing alpha and wild-type cases, and stratified Cox proportional hazards regression to compare the relative severity of alpha cases with wild-type diagnosed from 16 November 2020 to 11 January 2021. Results Using data from 185 234 people who tested positive for SARS-CoV-2 in the community (alpha = 93 153; wild-type = 92 081), in fully adjusted analysis accounting for individual-level demographics and comorbidities as well as regional variation in infection incidence, we found alpha associated with 73% higher hazards of all-cause death (adjusted hazard ratio [aHR]: 1.73; 95% confidence interval [CI]: 1.41-2.13; P < .0001) and 62% higher hazards of hospital admission (1.62; 1.48-1.78; P < .0001) compared with wild-type virus. Among patients already admitted to the intensive care unit, the association between alpha and increased all-cause mortality was smaller and the CI included the null (aHR: 1.20; 95% CI: .74-1.95; P = .45). Conclusions The SARS-CoV-2 alpha variant is associated with an increased risk of both hospitalization and mortality than wild-type virus. The SARS-CoV-2 alpha variant is associated with a 62% increased risk of hospitalization and a 73% increased risk of death, compared with the originally circulating wild-type virus in England between 16 November 2020 and 21 April 2021.

引用

页码：E1120 / E1127

页数：8

共 50 条

[31] Idiopathic Intracranial Hypertension Associated with SARS-CoV-2 B.1.1.7 Variant of Concern
Khalid, Muhammad Faran
Micieli, Jonathan A.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2022, 49 (03) : 472 - 473
[32] Multiorgan tropism of SARS-CoV-2 lineage B.1.1.7
Ondruschka, Benjamin
Heinrich, Fabian
Lindenmeyer, Maja
Edler, Carolin
Moebius, Dustin
Czogalla, Jan
Heinemann, Axel
Braun, Fabian
Aepfelbacher, Martin
Luetgehetmann, Marc
Huber, Tobias B.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE, 2021, 135 (06) : 2347 - 2349
[33] Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States
Alpert, Tara
Brito, Anderson F.
Lasek-Nesselquist, Erica
Rothman, Jessica
Valesano, Andrew L.
MacKay, Matthew J.
Petrone, Mary E.
Breban, Mallery, I
Watkins, Anne E.
Vogels, Chantal B. F.
Kalinich, Chaney C.
Dellicour, Simon
Russell, Alexis
Kelly, John P.
Shudt, Matthew
Plitnick, Jonathan
Schneider, Erasmus
Fitzsimmons, William J.
Khullar, Gaurav
Metti, Jessica
Dudley, Joel T.
Nash, Megan
Beaubier, Nike
Wang, Jianhui
Liu, Chen
Hui, Pei
Muyombwe, Anthony
Downing, Randy
Razeq, Jafar
Bart, Stephen M.
Grills, Ardath
Morrison, Stephanie M.
Murphy, Steven
Neal, Caleb
Laszlo, Eva
Rennert, Hanna
Cushing, Melissa
Westblade, Lars
Velu, Priya
Craney, Arryn
Cong, Lin
Peaper, David R.
Landry, Marie L.
Cook, Peter W.
Fauver, Joseph R.
Mason, Christopher E.
Lauring, Adam S.
St George, Kirsten
MacCannell, Duncan R.
Grubaugh, Nathan D.
CELL, 2021, 184 (10) : 2595 - +
[34] Structure-based evidence for the enhanced transmissibility of the dominant SARS-CoV-2 B.1.1.7 variant (Alpha)
Xia, Shuai
Wen, Zuoling
Wang, Lijue
Lan, Qiaoshuai
Jiao, Fanke
Tai, Linhua
Wang, Qian
Sun, Fei
Jiang, Shibo
Lu, Lu
Zhu, Yun
CELL DISCOVERY, 2021, 7 (01)
[35] Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) From a BNT162b2-Vaccinated Individual
Kerneis, Solen
Planas, Delphine
Imbeaud, Sandrine
Staropoli, Isabelle
Puech, Julien
Robillard, Nicolas
Rodary, Julien
Bruel, Timothee
Vieillard, Thomas
Schwartz, Olivier
Belec, Laurent
Pere, Helene
Veyer, David
OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (08):
[36] The first familial cluster of the B.1.1.7 variant of SARS-CoV-2 in the northeast of Italy
Lo Menzo, Sara
Marinello, Serena
Biasin, Matteo
Terregino, Calogero
Franchin, Elisa
Crisanti, Andrea
Cattelan, Annamaria
INFECTION, 2021, 49 (06) : 1341 - 1345
[37] Monitoring differences between the SARS-CoV-2 B.1.1.7 variant and other lineages
Jewell, Britta L.
LANCET PUBLIC HEALTH, 2021, 6 (05): : E267 - E268
[38] Anthropogenic Infection of Domestic Cats With SARS-CoV-2 Alpha Variant B.1.1.7 Lineage in Buenos Aires
Pecora, Andrea
Malacari, Dario Amilcar
Mozgovoj, Marina Valeria
Diaz, Maria de los angeles
Peralta, Andrea Veronica
Cacciabue, Marco
Puebla, Andrea Fabiana
Carusso, Cristian
Mundo, Silvia Leonor
Ledesma, Maria Mora Gonzalez Lopez
Gamarnik, Andrea Vanesa
Rinaldi, Osvaldo
Vidal, Osvaldo
Mas, Javier
Dus Santos, Maria Jose
FRONTIERS IN VETERINARY SCIENCE, 2022, 9
[39] Morphological appearance of the B.1.1.7 mutation of the novel coronavirus 2 (SARS-CoV-2) in chest CT
Kottlors, Jonathan
Fervers, Philipp
Geissen, Simon
Gertz, Roman Johannes
Bremm, Johannes
Rinneburger, Miriam
Weisthoff, Mathilda
Shahzad, Rahil
Maintz, David
Persigehl, Thorsten
QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2023, 13 (02) : 1058 - 1070
[40] Structural modelling of SARS-CoV-2 alpha variant (B.1.1.7) suggests enhanced furin binding and infectivity
Mohammad, Anwar
Abubaker, Jehad
Al-Mulla, Fahd
VIRUS RESEARCH, 2021, 303

← 1 2 3 4 5 →